Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Not all wealth building strategies are created equal. Discover the ones that truly work and can help you grow your finances effectively.
17,941 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Analysts lift HIMS, TDOC, and ALEC as strategic partnerships reduce key risks, prompting renewed upside potential and...
As markets navigate 2026, investors cling to long-term tech exposure. A fresh look at VGT argues it can anchor retire...
OpenAI CEO Sam Altman acknowledges AI is shifting the traditional labor-capital balance, highlighting job fears as au...
A fresh examination of the innovations powering U.S. military dominance and how investors are pricing defense names i...
Ohio is poised to boost its innovation engine. By conforming to the federal R&E immediate cost recovery rules, oh...
Headline rent figures hide true costs faced by tenants. This piece explains why the 'average rent' mirage misleads, a...
RF Industries (RFIL) faces a mix of aerospace, medical, and data-communications demand in 2026. This guide breaks dow...
Oilfield services stocks led by Baker Hughes, Halliburton, and Transocean each rose around 5% as crude oil prices jum...
A rare misfire during a live-fire demonstration over Camp Pendleton unleashed shrapnel on California's I-5. The Marin...
A new car loan interest deduction could trim tax bills for buyers of eligible U.S.-assembled vehicles. Here’s who qua...
A major healthcare-focused fund just nudged its bets into a wearable heart-monitor company. This move spotlights the ...